Published in EMBO J on October 01, 2002
Panallergens and their impact on the allergic patient. Allergy Asthma Clin Immunol (2010) 1.18
Structure of the N-terminal regulatory domain of a plant NADPH oxidase and its functional implications. J Biol Chem (2009) 1.03
Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain. Biochemistry (2011) 0.96
Structure of allergens and structure based epitope predictions. Methods (2013) 0.86
Stabilization of the dimeric birch pollen allergen Bet v 1 impacts its immunological properties. J Biol Chem (2013) 0.84
Two structural motifs within canonical EF-hand calcium-binding domains identify five different classes of calcium buffers and sensors. PLoS One (2014) 0.78
Characterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapy. Immunobiology (2013) 0.77
100 Years later: Celebrating the contributions of x-ray crystallography to allergy and clinical immunology. J Allergy Clin Immunol (2015) 0.75
Solution structure and backbone dynamics of Calsensin, an invertebrate neuronal calcium-binding protein. Protein Sci (2005) 0.75
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibody. Allergy (2015) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr (1999) 41.65
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Automated protein model building combined with iterative structure refinement. Nat Struct Biol (1999) 27.52
Maximum-likelihood density modification. Acta Crystallogr D Biol Crystallogr (2000) 20.67
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr D Biol Crystallogr (1994) 7.53
3D domain swapping: a mechanism for oligomer assembly. Protein Sci (1995) 4.96
Carp muscle calcium-binding protein. II. Structure determination and general description. J Biol Chem (1973) 4.87
Structure of calmodulin refined at 2.2 A resolution. J Mol Biol (1988) 4.65
3D domain swapping: as domains continue to swap. Protein Sci (2002) 4.35
Allergy and allergic diseases. First of two parts. N Engl J Med (2001) 4.33
The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol (2001) 3.98
Tip-localized calcium entry fluctuates during pollen tube growth. Dev Biol (1996) 3.09
Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci U S A (1977) 3.07
Lipids are required for directional pollen-tube growth. Nature (1998) 2.74
Signaling and the modulation of pollen tube growth Plant Cell (1999) 2.23
EF-hand calcium-binding proteins. Curr Opin Struct Biol (2000) 2.13
Diversity of conformational states and changes within the EF-hand protein superfamily. Proteins (1999) 1.79
One-step evolution of a dimer from a monomeric protein. Nat Struct Biol (1995) 1.75
A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature (1993) 1.64
Allergy and allergic diseases. Second of two parts. N Engl J Med (2001) 1.58
The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol (2002) 1.41
Three-dimensional domain duplication, swapping and stealing. Curr Opin Struct Biol (1997) 1.25
An extended hydrophobic core induces EF-hand swapping. Protein Sci (2001) 1.13
A novel mode of target recognition suggested by the 2.0 A structure of holo S100B from bovine brain. Structure (1998) 1.07
The folding pathway of the cell-cycle regulatory protein p13suc1: clues for the mechanism of domain swapping. Structure (2000) 0.98
Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem (1997) 0.94
Molecular, structural, and immunologic relationships between different families of recombinant calcium-binding pollen allergens. J Allergy Clin Immunol (2002) 0.89
Calcium-binding allergens: from plants to man. Int Arch Allergy Immunol (1998) 0.88
Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy. Biol Chem (1999) 0.85
Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem Biophys Res Commun (1997) 0.84
Molecular cloning and immunological characterisation of Cyn d 7, a novel calcium-binding allergen from Bermuda grass pollen. FEBS Lett (1997) 0.84
The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases. Int Arch Allergy Immunol (1998) 0.84
Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev (2001) 0.83
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7. FASEB J (1999) 0.83
Ole e 3, an olive-tree allergen, belongs to a widespread family of pollen proteins. Eur J Biochem (1996) 0.81
Localization of the Ca(2+)-binding protein, Bra r 1, in anthers and pollen tubes. Plant Cell Physiol (1999) 0.80
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition. J Immunol (1998) 0.80
Identification of a Ca2+ binding protein as a new Bermuda grass pollen allergen Cyn d 7: IgE cross-reactivity with oilseed rape pollen allergen Bra r 1. Int Arch Allergy Immunol (1997) 0.78
A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol (2005) 5.43
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
RNA-specific ribonucleotidyl transferases. RNA (2007) 2.15
Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length. Cell Rep (2012) 2.07
A role for SSU72 in balancing RNA polymerase II transcription elongation and termination. Mol Cell (2002) 2.06
Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol (2012) 2.05
WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol (2005) 1.97
Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. EMBO J (2004) 1.92
Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3' end processing and splicing. Mol Cell (2006) 1.86
Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol (2010) 1.80
An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. EMBO J (2006) 1.79
Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein interactions, and subcellular localization. J Biol Chem (2004) 1.78
The structure and binding behavior of the bacterial cell surface layer protein SbsC. Structure (2008) 1.72
Independent functions of yeast Pcf11p in pre-mRNA 3' end processing and in transcription termination. EMBO J (2003) 1.72
Yhh1p/Cft1p directly links poly(A) site recognition and RNA polymerase II transcription termination. EMBO J (2002) 1.71
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J (2002) 1.66
RNA editing by adenosine deaminases generates RNA and protein diversity. Biochimie (2002) 1.64
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol (2008) 1.64
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol (2011) 1.63
High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy. J Allergy Clin Immunol (2012) 1.52
Functional analysis of yeast snoRNA and snRNA 3'-end formation mediated by uncoupling of cleavage and polyadenylation. Mol Cell Biol (2002) 1.49
Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy. J Allergy Clin Immunol (2011) 1.49
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol (2002) 1.47
Wheat allergy in children evaluated with challenge and IgE antibodies to wheat components. Pediatr Allergy Immunol (2015) 1.44
Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE. Immunol Cell Biol (2012) 1.41
tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli. EMBO J (2002) 1.38
High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. J Immunol (2009) 1.37
Distinct roles of non-canonical poly(A) polymerases in RNA metabolism. PLoS Genet (2009) 1.33
Structural basis for nucleic acid and toxin recognition of the bacterial antitoxin CcdA. J Mol Biol (2006) 1.32
Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals. EMBO J (2007) 1.27
Biochemical and structural insights into substrate binding and catalytic mechanism of mammalian poly(A) polymerase. J Mol Biol (2004) 1.26
Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice. J Immunol (2005) 1.22
Functions for S. cerevisiae Swd2p in 3' end formation of specific mRNAs and snoRNAs and global histone 3 lysine 4 methylation. RNA (2004) 1.22
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol (2011) 1.15
Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol (2002) 1.15
The role of the yeast cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-mRNA 3'-end formation. Nucleic Acids Res (2003) 1.15
Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol (2013) 1.14
The solution structure of ParD, the antidote of the ParDE toxin antitoxin module, provides the structural basis for DNA and toxin binding. Protein Sci (2007) 1.14
Sequence motifs that distinguish ATP(CTP):tRNA nucleotidyl transferases from eubacterial poly(A) polymerases. RNA (2004) 1.14
Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol (2004) 1.13
Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J Immunol (2007) 1.09
Impaired allergy diagnostics among parasite-infected patients caused by IgE antibodies to the carbohydrate epitope galactose-α 1,3-galactose. J Allergy Clin Immunol (2011) 1.09
Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol (2006) 1.09
Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol (2010) 1.07
Suggestions for the assessment of the allergenic potential of genetically modified organisms. Int Arch Allergy Immunol (2005) 1.06
Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J Mol Biol (2007) 1.06
The anti-toxin ParD of plasmid RK2 consists of two structurally distinct moieties and belongs to the ribbon-helix-helix family of DNA-binding proteins. Biochem J (2002) 1.06
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J Immunol (2005) 1.05
Gene regulation: reviving the message. Nature (2002) 1.05
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood (2008) 1.05
B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J Allergy Clin Immunol (2007) 1.05
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol (2005) 1.04
Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem (2003) 1.04
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur J Immunol (2002) 1.03
Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy. J Immunol (2002) 1.03
Release of allergens as respirable aerosols: A link between grass pollen and asthma. J Allergy Clin Immunol (2002) 1.03
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine (2011) 1.01
Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol (2003) 1.00
Cleavage factor Im is a key regulator of 3' UTR length. RNA Biol (2012) 1.00
Crystal structure of the 25 kDa subunit of human cleavage factor Im. Nucleic Acids Res (2008) 0.99
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering. Mol Immunol (2008) 0.99
A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J Allergy Clin Immunol (2005) 0.99
PAPD5, a noncanonical poly(A) polymerase with an unusual RNA-binding motif. RNA (2011) 0.99
FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol (2004) 0.98
TraA and its N-terminal relaxase domain of the Gram-positive plasmid pIP501 show specific oriT binding and behave as dimers in solution. Biochem J (2005) 0.98
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol (2009) 0.98
Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol (2012) 0.97
Mast cell-derived proteases control allergic inflammation through cleavage of IgE. J Allergy Clin Immunol (2007) 0.97
Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity. J Allergy Clin Immunol (2011) 0.97
Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol (2007) 0.96
Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol (2006) 0.96
Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants. J Allergy Clin Immunol (2006) 0.96
Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy. Int Arch Allergy Immunol (2008) 0.95
Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy. J Allergy Clin Immunol (2011) 0.95
Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense. J Nat Prod (2011) 0.95
Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library. J Allergy Clin Immunol (2004) 0.94
Skin prick test extracts for dog allergy diagnosis show considerable variations regarding the content of major and minor dog allergens. Int Arch Allergy Immunol (2010) 0.94
The 2.5 Å structure of the enterococcus conjugation protein TraM resembles VirB8 type IV secretion proteins. J Biol Chem (2012) 0.94
Molecular determinants of allergen-induced effector cell degranulation. J Allergy Clin Immunol (2006) 0.94
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol (2002) 0.92
Allergy testing: the role of recombinant allergens. Clin Chem Lab Med (2006) 0.92
The TraA relaxase autoregulates the putative type IV secretion-like system encoded by the broad-host-range Streptococcus agalactiae plasmid pIP501. Microbiology (2006) 0.92
Conjugative type IV secretion systems in Gram-positive bacteria. Plasmid (2013) 0.92
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int Arch Allergy Immunol (2005) 0.91